Locally advanced head and neck squamous cell carcinoma and melanoma simultaneously treated with pembrolizumab: an unusual situation

European Journal of Dermatology volume 30, pages743–744(2020)Cite this article

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

US$ 39.95

Tax calculation will be finalised during checkout.

References

  1. 1.

    Lomas A, Leonardi-Bee J, Bath-Hextall F. A systematic review of worldwide incidence of nonmelanoma skin cancer. Br J Dermatol 2012; 166: 1069–80.

    CAS  Article  Google Scholar 

  2. 2.

    Stevenson ML, Wang CQ, Abikhair M, et al. Expression of programmed cell death ligand in cutaneous squamous cell carcinoma and treatment of locally advanced disease with pembrolizumab. JAMA Dermatol 2017; 153: 299–303.

    Article  Google Scholar 

  3. 3.

    Cohen EEW, Soulières D, LeTourneau C, et al. Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study. Lancet 2019; 393: 156–67.

    CAS  Article  Google Scholar 

  4. 4.

    Eggermont AMM, Blank CU, Mandala M, et al. adjuvant pembrolizumab versus placebo in resected Stage III melanoma. N Engl J Med 2018; 378: 1789–801.

    CAS  Article  Google Scholar 

  5. 5.

    Lee CH, Yelensky R, Jooss K, Chan TA. Update on tumor neoantigens and their utility: why it is good to be different. Trends Immunol 2018; 39: 536–48.

    CAS  Article  Google Scholar 

  6. 6.

    Garcia-Diez I, Hernandez-Ruiz E, Andrades E, et al. PD-L1 Expression is increased in metastasizing squamous cell carcinomas and their metastases. Am J Dermatopathol 2018; 40: 647–54.

    Article  Google Scholar 

  7. 7.

    Veness MJ, Quinn DI, Ong CS, et al. Aggressive cutaneous malignancies following cardiothoracic transplantation: The Australian experience. Cancer 1999; 85: 1758–64.

    CAS  Article  Google Scholar 

  8. 8.

    Euvrard S, Kanitakis J, Claudy A. Skin cancers after organ transplantation. N Engl J Med 2003; 348: 1681–91.

    Article  Google Scholar 

  9. 9.

    Euvrard S, Kanitakis J, Decullier E, et al. Subsequent skin cancers in kidney and heart transplant recipients after the first squamous cell carcinoma. Transplantation 2006; 81: 1093–100.

    Article  Google Scholar 

  10. 10.

    Saavedra D, García B. Immunosenescence: effects of aging process on immune system. Rev Cubana Hematol Inmunol Hemoter 2014; 30: 332–45.

    Google Scholar 

Download references

Author information

Affiliations

  1. Dermatology Department Hospital Universitari Germans Trias i Pujol, Fundació Institut d’Investigació en Ciències de la Salut Germans Trias i Pujol, Universitat Autónoma de Barcelona, Badalona, Barcelona, Spain

    Verónica Mora-Fernández, Aram Boada, Ane Jaka & Carlos Ferrándiz

  2. Oncology Department, Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, Spain

    José-Luis Manzano

Authors
  1. Verónica Mora-Fernández
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Aram Boada
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. José-Luis Manzano
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ane Jaka
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Carlos Ferrándiz
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Verónica Mora-Fernández.

Additional information

Disclosures

Financial support: none. Conflicts of interest: none.

About this article

Verify currency and authenticity via CrossMark

Cite this article

Mora-Fernández, V., Boada, A., Manzano, JL. et al. Locally advanced head and neck squamous cell carcinoma and melanoma simultaneously treated with pembrolizumab: an unusual situation. Eur J Dermatol 30, 743–744 (2020). https://doi.org/10.1684/ejd.2020.3911

Download citation